These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. US Supreme Court applies strict limits to patents. Robertson D Nat Biotechnol; 2002 Jul; 20(7):639. PubMed ID: 12089532 [No Abstract] [Full Text] [Related]
3. Patents. U.S. Supreme Court delves into what is and isn't patentable. Marshall E Science; 2009 Jun; 324(5933):1374. PubMed ID: 19520926 [No Abstract] [Full Text] [Related]
4. Intellectual property. Supreme Court rules out patents on 'natural' genes. Marshall E Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772 [No Abstract] [Full Text] [Related]
10. Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents. Teitelbaum R; Cohen M Nat Biotechnol; 2007 Oct; 25(10):1105-6. PubMed ID: 17921990 [No Abstract] [Full Text] [Related]
11. Intellectual property. Biotech feels a chill from changing U.S. patent rules. Servick K Science; 2014 Jul; 345(6192):14-5. PubMed ID: 24994626 [No Abstract] [Full Text] [Related]
12. US personalized-medicine industry takes hit from Supreme Court. Ledford H Nature; 2016 Aug; 536(7617):382. PubMed ID: 27558042 [No Abstract] [Full Text] [Related]
13. Patentable subject matter, TRIPS and the European Biotechnology Directive: Australia and patenting human genes. Palombi L Univ N S W Law J; 2003; 26(3):782-92. PubMed ID: 16617532 [No Abstract] [Full Text] [Related]
14. Festo and the US Supreme Court: be careful what you wish for. Gogoris AC; Lee SS Nat Biotechnol; 2002 Aug; 20(8):845-6. PubMed ID: 12148011 [No Abstract] [Full Text] [Related]
15. US Supreme Court decision could compromise biotech patents. Robertson D Nat Biotechnol; 2001 May; 19(5):394. PubMed ID: 11328981 [No Abstract] [Full Text] [Related]
16. Pharmaceutical patent life-cycle management after KSR v. Teleflex. Furrow ME Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462 [No Abstract] [Full Text] [Related]
18. Chemistry and the law. Grant JL Pharm Pat Anal; 2012 Jul; 1(3):241-3. PubMed ID: 24236835 [TBL] [Abstract][Full Text] [Related]
19. The gene patenting controversy: a convergence of law, economic interests, and ethics. Kevles DJ; Berkowitz A Brooklyn Law Rev; 2001; 67(1):233-48. PubMed ID: 12645549 [No Abstract] [Full Text] [Related]
20. Ordering life: law and the normalization of biotechnology. Jasanoff S Not Polit; 2001; 17(62):34-50. PubMed ID: 15468485 [No Abstract] [Full Text] [Related] [Next] [New Search]